Search For "fda"
CPhI and Informa Pharma Intelligence concluded the 3rd Biopharma Conclave
Updated : 4 years, 5 months ago IST
Hyderabad (Telangana) [India], October 1 (ANI/PRNewswire): Informa Pharma Intelligence, one of the leading business intelligence providers and knowledge partners, has today concluded the 3rd edition of the Biopharma Conclave conducted by CPhI.
Read More
US FDA authorizes Pfizer's Covid booster shots for elderly, high-risk Amer
Updated : 4 years, 6 months ago IST
Washington [US], September 23 (ANI): US Food and Drug Administration (FDA) on Wednesday (local time) authorized booster shots of the Pfizer COVID-19 vaccine for those aged 65 and older and adults at high risk.
Read More
Glenmark Pharmaceuticals receives ANDA approval for Clindamycin Phosphate
Updated : 4 years, 6 months ago IST
Mumbai (Maharashtra) [India], September 21 (ANI/PR Newswire): Glenmark Pharmaceuticals Ltd. (Glenmark) has received final approval by the United States Food & Drug Administration (U.S. FDA) for Clindamycin Phosphate Foam, 1%, the generic version of Evoclin®1 Foam, 1%, of Mylan Pharm
Read More
US FDA: No Pfizer booster shots for 16 and above, approved only for people
Updated : 4 years, 6 months ago IST
Washington [US], September 18 (ANI): The US Food and Drug Administration advisory (FDA) committee on Friday (local time) voted unanimously to authorize Pfizer booster shots for use in people aged 65-plus and high-risk patients following a prior failed vote to approve third shots for all p
Read More
US: FDA gives full approval to Pfizer-BioNTech COVID 19 vaccine
Updated : 4 years, 7 months ago IST
Washington [US] August 23 (ANI): The US Food and Drug Administration (FDA) on Monday gave full approval to Pfizer's COVID-19 vaccine.
Read More
Pfizer and BioNTech announce submission of Initial data to US FDA to suppo
Updated : 4 years, 7 months ago IST
New York [US], August 17 (ANI): Pfizer and BioNTech announced that they have submitted Phase 1 data to the United States Food and Drug Administration (FDA) to support the evaluation of a third, or booster dose of the companies' COVID-19 vaccine for future licensure.
Read More
Immunocompromised people in US to get 3rd dose of COVID-19 vaccines
Updated : 4 years, 7 months ago IST
Washington [US], August 13 (ANI/Sputnik): The US Food and Drug Administration (FDA) has authorized the emergency use of the third dose of both Moderna and Pfizer vaccines against COVID-19 for immunocompromised people.
Read More
FDA warns of rare neurological complication with J&J coronavirus vacci
Updated : 4 years, 8 months ago IST
Washington [US], July 13 (ANI): The US Food and Drug Administration (FDA) on Monday (local time) warned coronavirus vaccine maker Johnson & Johnson of possible rare neurological complications caused due to its dose.
Read More
Wobot.ai, the AI-powered video analytics platform, announces launch of new
Updated : 4 years, 8 months ago IST
New Delhi [India], July 10 (ANI/PRNewswire): Wobot.ai, the AI-powered video analytics platform, today announced the launch of a new SaaS-based and simplified version of its product.
Read More
Growing and glowing with Cozmoderm Clinic
Updated : 4 years, 8 months ago IST
New Delhi [India], June 30 (ANI/SRV Media): Cozmoderm Clinic is redefining the new generation of aesthetics and beauty industry by serving dermatological and cosmetic solutions in a holistic environment.
Read More
US faces calls from experts to speed up COVID-19 vaccine approval process
Updated : 4 years, 8 months ago IST
Washington [US], June 28 (ANI): As the United States is poised to miss its July 4 goal of vaccinating 70 per cent of adult Americans, calls are rising from some experts for the Food and Drug Administration (FDA) to move faster to fully approve the COVID-19 vaccines as a key step to address v
Read More
Glenmark Pharmaceuticals receives ANDA tentative approval for Nintedanib C
Updated : 4 years, 9 months ago IST
Mumbai (Maharashtra) [India], June 25 (ANI/PRNewswire): Glenmark Pharmaceuticals Ltd (Glenmark) has received tentative approval by the United States Food & Drug Administration (U.S. FDA) for Nintedanib Capsules, 100 mg and 150 mg, the generic version of Ofev®1 Capsules, 100 mg and 1
Read More